Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
19352 | 509 | 43.0 | 94% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
636 | 3 | TIGHT JUNCTION//NOONAN SYNDROME//CLAUDIN | 12838 |
1574 | 2 | TIGHT JUNCTION//NOONAN SYNDROME//CLAUDIN | 7292 |
19352 | 1 | CD47//BIOSIGNAL SCI//SHPS 1 | 509 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CD47 | authKW | 2614513 | 18% | 48% | 91 |
2 | BIOSIGNAL SCI | address | 1495108 | 7% | 69% | 36 |
3 | SHPS 1 | authKW | 1339053 | 5% | 89% | 25 |
4 | SIRP ALPHA | authKW | 906687 | 5% | 66% | 23 |
5 | SECT HISTOL CELL BIOL | address | 528882 | 5% | 38% | 23 |
6 | INTEGRIN ASSOCIATED PROTEIN | authKW | 470308 | 3% | 56% | 14 |
7 | SIGNAL REGULATORY PROTEIN ALPHA | authKW | 461455 | 2% | 77% | 10 |
8 | LUDWIG CANC STEM CELL MED | address | 194355 | 2% | 36% | 9 |
9 | SIRP | authKW | 191958 | 2% | 40% | 8 |
10 | MORT CELLULAIRE PROGRAMMEE PHYSIOPATHOL CELLULE | address | 179969 | 1% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 1521 | 27% | 0% | 138 |
2 | Cell Biology | 740 | 21% | 0% | 106 |
3 | Biochemistry & Molecular Biology | 611 | 31% | 0% | 159 |
4 | Hematology | 457 | 10% | 0% | 50 |
5 | Oncology | 209 | 12% | 0% | 63 |
6 | Medicine, Research & Experimental | 121 | 7% | 0% | 35 |
7 | Biophysics | 50 | 5% | 0% | 24 |
8 | Neurosciences | 37 | 8% | 0% | 39 |
9 | Endocrinology & Metabolism | 27 | 4% | 0% | 21 |
10 | Materials Science, Biomaterials | 23 | 1% | 0% | 7 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOSIGNAL SCI | 1495108 | 7% | 69% | 36 |
2 | SECT HISTOL CELL BIOL | 528882 | 5% | 38% | 23 |
3 | LUDWIG CANC STEM CELL MED | 194355 | 2% | 36% | 9 |
4 | MORT CELLULAIRE PROGRAMMEE PHYSIOPATHOL CELLULE | 179969 | 1% | 100% | 3 |
5 | MOL CELLULAR SIGNALING | 171843 | 4% | 15% | 19 |
6 | MOL CELLULAR REGULAT | 170970 | 9% | 6% | 48 |
7 | HEMATOL IMMUNOL ONCOL | 146966 | 1% | 35% | 7 |
8 | PROGRAM CELLULAR BIOL IMMUNOL | 134976 | 1% | 75% | 3 |
9 | INTEGRAT MED BIOL | 83474 | 6% | 5% | 29 |
10 | INFECT DIS MOL MICROBIOL | 79985 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF IMMUNOLOGY | 2032 | 8% | 0% | 43 |
2 | JOURNAL OF BIOLOGICAL CHEMISTRY | 1012 | 10% | 0% | 52 |
3 | EXPERIMENTAL DIABETES RESEARCH | 755 | 0% | 1% | 2 |
4 | BLOOD | 603 | 4% | 0% | 19 |
5 | SCIENCE TRANSLATIONAL MEDICINE | 600 | 1% | 0% | 4 |
6 | TRANSFUSION CLINIQUE ET BIOLOGIQUE | 482 | 1% | 0% | 3 |
7 | EUROPEAN JOURNAL OF IMMUNOLOGY | 441 | 2% | 0% | 10 |
8 | TRENDS IN IMMUNOLOGY | 413 | 1% | 0% | 3 |
9 | TRANSFUSION MEDICINE AND HEMOTHERAPY | 387 | 0% | 0% | 2 |
10 | JOURNAL OF EXPERIMENTAL MEDICINE | 382 | 2% | 0% | 9 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CD47 | 2614513 | 18% | 48% | 91 | Search CD47 | Search CD47 |
2 | SHPS 1 | 1339053 | 5% | 89% | 25 | Search SHPS+1 | Search SHPS+1 |
3 | SIRP ALPHA | 906687 | 5% | 66% | 23 | Search SIRP+ALPHA | Search SIRP+ALPHA |
4 | INTEGRIN ASSOCIATED PROTEIN | 470308 | 3% | 56% | 14 | Search INTEGRIN+ASSOCIATED+PROTEIN | Search INTEGRIN+ASSOCIATED+PROTEIN |
5 | SIGNAL REGULATORY PROTEIN ALPHA | 461455 | 2% | 77% | 10 | Search SIGNAL+REGULATORY+PROTEIN+ALPHA | Search SIGNAL+REGULATORY+PROTEIN+ALPHA |
6 | SIRP | 191958 | 2% | 40% | 8 | Search SIRP | Search SIRP |
7 | SIGNAL REGULATORY PROTEIN | 159970 | 1% | 67% | 4 | Search SIGNAL+REGULATORY+PROTEIN | Search SIGNAL+REGULATORY+PROTEIN |
8 | P84 | 149969 | 1% | 50% | 5 | Search P84 | Search P84 |
9 | DONT EAT ME SIGNAL | 119980 | 0% | 100% | 2 | Search DONT+EAT+ME+SIGNAL | Search DONT+EAT+ME+SIGNAL |
10 | IAP CD47 | 119980 | 0% | 100% | 2 | Search IAP+CD47 | Search IAP+CD47 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BARCLAY, AN , VAN DEN BERG, TK , (2014) THE INTERACTION BETWEEN SIGNAL REGULATORY PROTEIN ALPHA (SIRP ALPHA) AND CD47: STRUCTURE, FUNCTION, AND THERAPEUTIC TARGET.ANNUAL REVIEW OF IMMUNOLOGY, VOL 32. VOL. 32. ISSUE . P. 25 -50 | 105 | 71% | 51 |
2 | MATOZAKI, T , MURATA, Y , OKAZAWA, H , OHNISH, H , (2009) FUNCTIONS AND MOLECULAR MECHANISMS OF THE CD47-SIRP ALPHA SIGNALLING PATHWAY.TRENDS IN CELL BIOLOGY. VOL. 19. ISSUE 2. P. 72 -80 | 72 | 86% | 118 |
3 | MURATA, Y , KOTANI, T , OHNISHI, H , MATOZAKI, T , (2014) THE CD47-SIRP ALPHA SIGNALLING SYSTEM: ITS PHYSIOLOGICAL ROLES AND THERAPEUTIC APPLICATION.JOURNAL OF BIOCHEMISTRY. VOL. 155. ISSUE 6. P. 335-344 | 60 | 81% | 11 |
4 | SICK, E , JEANNE, A , SCHNEIDER, C , DEDIEU, S , TAKEDA, K , MARTINY, L , (2012) CD47 UPDATE: A MULTIFACETED ACTOR IN THE TUMOUR MICROENVIRONMENT OF POTENTIAL THERAPEUTIC INTEREST.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 167. ISSUE 7. P. 1415-1430 | 73 | 50% | 26 |
5 | ZHANG, L , HUANG, H , (2016) TARGETING THE CANCER BIOMARKER CD47: A REVIEW ON THE DIVERSE MECHANISMS OF THE CD47 PATHWAY IN CANCER TREATMENT.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 16. ISSUE 6. P. 658 -667 | 55 | 59% | 1 |
6 | LIN, Y , YAN, XQ , YANG, F , YANG, XW , JIANG, X , ZHAO, XC , ZHU, BK , LIU, L , QIN, HY , LIANG, YM , ET AL (2012) SOLUBLE EXTRACELLULAR DOMAINS OF HUMAN SIRP ALPHA AND CD47 EXPRESSED IN ESCHERICHIA COLI ENHANCES THE PHAGOCYTOSIS OF LEUKEMIA CELLS BY MACROPHAGES IN VITRO.PROTEIN EXPRESSION AND PURIFICATION. VOL. 85. ISSUE 1. P. 109 -116 | 35 | 95% | 2 |
7 | SARFATI, M , FORTIN, G , RAYMOND, M , SUSIN, S , (2008) CD47 IN THE IMMUNE RESPONSE: ROLE OF THROMBOSPONDIN AND SIRP-ALPHA REVERSE SIGNALING.CURRENT DRUG TARGETS. VOL. 9. ISSUE 10. P. 842-850 | 60 | 55% | 31 |
8 | CHEN, TT , BROWN, EJ , HUANG, EJ , SEAMAN, WE , (2004) EXPRESSION AND ACTIVATION OF SIGNAL REGULATORY PROTEIN ALPHA ON ASTROCYTOMAS.CANCER RESEARCH. VOL. 64. ISSUE 1. P. 117-127 | 47 | 82% | 9 |
9 | OLDENBORG, PA , (2012) ROLE OF CD47 AND SIGNAL REGULATORY PROTEIN ALPHA (SIRP ALPHA) IN REGULATING THE CLEARANCE OF VIABLE OR AGED BLOOD CELLS.TRANSFUSION MEDICINE AND HEMOTHERAPY. VOL. 39. ISSUE 5. P. 315 -320 | 51 | 59% | 2 |
10 | BIAN, Z , SHI, L , GUO, YL , LV, ZY , TANG, C , NIU, S , TREMBLAY, A , VENKATARAMANI, M , CULPEPPER, C , LI, LM , ET AL (2016) CD47-SIRP ALPHA INTERACTION AND IL-10 CONSTRAIN INFLAMMATION-INDUCED MACROPHAGE PHAGOCYTOSIS OF HEALTHY SELF-CELLS.PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. VOL. 113. ISSUE 37. P. E5434 -E5443 | 40 | 63% | 1 |
Classes with closest relation at Level 1 |